Guangdong Lifestrong Pharmacy Co. Ltd. (301111) - Total Liabilities

Latest as of March 2026: CN¥147.30 Million CNY ≈ $21.56 Million USD

Based on the latest financial reports, Guangdong Lifestrong Pharmacy Co. Ltd. (301111) has total liabilities worth CN¥147.30 Million CNY (≈ $21.56 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Guangdong Lifestrong Pharmacy Co. Ltd. to evaluate the company's liquid asset resilience ratio.

Guangdong Lifestrong Pharmacy Co. Ltd. - Total Liabilities Trend (2017–2025)

This chart illustrates how Guangdong Lifestrong Pharmacy Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Guangdong Lifestrong Pharmacy Co. Ltd..

Guangdong Lifestrong Pharmacy Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Guangdong Lifestrong Pharmacy Co. Ltd. ranked by their total liabilities.

Company Country Total Liabilities
goeasy Ltd
TO:GSY
Canada CA$4.97 Billion
Kaufman Et Broad
PA:KOF
France €1.21 Billion
B&S Group SA
AS:BSGR
Netherlands €699.29 Million
Solowin Holdings Ordinary Share
NASDAQ:SWIN
USA $7.58 Million
Shanghai Phoenix Enterprise Group Co Ltd A
SHG:600679
China CN¥1.14 Billion
Guizhou Transp Planning
SHG:603458
China CN¥2.70 Billion
Rayonier Advanced Materials
NYSE:RYAM
USA $1.44 Billion
Guangdong Sanhe Pile Co Ltd
SHE:003037
China CN¥4.09 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Guangdong Lifestrong Pharmacy Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Guangdong Lifestrong Pharmacy Co. Ltd. (301111) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 6.48 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.16 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guangdong Lifestrong Pharmacy Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2025)

The table below shows the annual total liabilities of Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥142.91 Million
≈ $20.91 Million
-14.12%
2024-12-31 CN¥166.42 Million
≈ $24.35 Million
+115.20%
2023-12-31 CN¥77.33 Million
≈ $11.32 Million
-21.41%
2022-12-31 CN¥98.39 Million
≈ $14.40 Million
+30.59%
2021-12-31 CN¥75.34 Million
≈ $11.03 Million
+24.80%
2020-12-31 CN¥60.37 Million
≈ $8.83 Million
+12.69%
2019-12-31 CN¥53.57 Million
≈ $7.84 Million
-20.80%
2018-12-31 CN¥67.64 Million
≈ $9.90 Million
-40.95%
2017-12-31 CN¥114.55 Million
≈ $16.76 Million
--

About Guangdong Lifestrong Pharmacy Co. Ltd.

SHE:301111 China Drug Manufacturers - Specialty & Generic
Market Cap
$492.38 Million
CN¥3.36 Billion CNY
Market Cap Rank
#12346 Global
#3562 in China
Share Price
CN¥21.03
Change (1 day)
+2.99%
52-Week Range
CN¥15.51 - CN¥30.31
All Time High
CN¥56.05
About

Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. It operates through Medical Services and Health Management; and Health Consumer Products segments. The company produces tablets, hard capsules, injections, and pills, and other related products. It also offers respiratory, pediatric, gynecology, urinary, and nutrition and… Read more